A Study of Blood Clotting Response in Patients with a Traumatic Injury

Overview

Información sobre este estudio

The purpose of this study is to look at the blood’s clotting response in people who have suffered a traumatic injury and compare it with non-injured people.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Trauma patients who arrive to Mayo Clinic Hospital - Saint Marys Emergency Deparment and are classified as Level Red and Yellow activations.
  • Male and female patients 18 years of age or older (no upper age limit).
  • Blunt and/or penetrating traumatic injuries.

Exclusion Criteria:

  • Are on therapeutic anticoagulation, to include Coumadin/Pradaxa or antiplatelet agents (excluding Plavix, aspirin or ibuprofen).
  • Have preexisting coagulopathy (cirrhosis and inherited clotting disorders including Hemophilia A & B, Factor IX, Factor XI deficiencies).
  • Patients greater than 12 hours from time of injury.
  • Have history of known malignancy (no clinical evidence within 3 months).
  • Active diagnosis of sepsis at the time of injury.
  • Renal failure on dialysis.
  • Patients with thermal injuries ( not including “road rashes”).
  • Patients on high dose steroids or autoimmune medications.
  • Patients who have experienced traumatic injuries within the past 1 year.
  • Known pPregnancy.
  • Prisoners.
  • Have a preexisting medical condition that, in the judgment of the investigator, would preclude participation in this study.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Myung Park, M.D., M.S.

Abierto para la inscripción

Contact information:

Amy Headlee CCRP, SOCRA

(507)422-0406

More information

Publicaciones

Publications are currently not available